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ABSTRACT: Lantibiotics are (methyl)lanthionine-containing bacterial peptides. (Methyl)lanthionines are
posttranslationally introduced into the prepropeptides by biosynthetic enzymes that dehydrate serines and
threonines and couple these dehydrated residues to cysteine residues. Thirty seven lantibiotic primary
structures have been proposed to date, but little is known about the substrate specificity of the lantibiotic
modifying enzymes. To define rules for the rational design of modified peptides, we compared all known
lantibiotic structures by in silico analysis. Although no strict sequence motifs can be defined that govern
the modification, statistical analysis demonstrates that dehydratable serines and threonines are more often
flanked by hydrophobic than by hydrophilic amino acids. Serine residues escape dehydration more often
than threonines. With these rules, novel hexapeptides were designed that either were predicted to become
modified or will escape modification. The hexapeptides were fused to the nisin leader and expressed in
a Lactococcus lactis strain containing the nisin modifying and export enzymes. The excreted peptides
were analyzed by mass spectrometry. All designed fusion peptides were produced, and the presence or
absence of modifications was found to be in full agreement with the predictions based on the statistical
analysis. These findings demonstrate the feasibility of the rational design of a wide range of novel peptides
with dehydrated amino acid residues.
Peptides and proteins can be modified in various ways in
order to improve their therapeutic use, for instance, by
coupling to poly(ethylene glycol) or by glycosylation,
amidation, and backbone cyclization. Local backbone cy-
clization limits the conformational freedom of a (poly)-
peptide, which allows modulation of its activity and speci-
ficity (1). In addition, the constrained cyclized structure
protects (poly)peptides against proteolytic action (1-3).
Stabilization of therapeutic peptides by cyclization may allow
longer storage, lower doses, and less frequent administration
to patients. The potential impact of cyclization is, for
instance, illustrated by the fact that thioether-containing
enkephalin showed no proteolytic degradation in rat brain
homogenate, whereas Leu-enkephalin without the thioether
ring is degraded for 50% in less than 7 min (4). Thioether
enkephalin is in vivo extremely effective (5).
Therapeutic peptides of modest size have been chemically
cyclized, which enhanced or modulated their activity (1, 5).
Chemical methods, however, face several drawbacks, such
as lack of stereo- and regiospecificity, multimerization instead
of cyclization, and inefficient multistep synthesis involving
the use of protecting groups. Chemical approaches are
meeting limits especially when applied for the synthesis of
larger peptides with multiple ring structures.
Enzymatic cyclization overcomes several of the challenges
for chemical synthesis and occurs during the synthesis of,
for instance, the cyclic antibiotics, tyrocidine and gramicidin
S, and of the lipoheptapeptide surfactin A (6, 7). Isolated
thioesterase domains of the nonribosomal peptide synthetases
of the above antibiotics retain their activity. These domains
cyclize the peptides head to tail or head to side chain.
Peptide backbone modifications, comprising head to tail
cyclization but also thiazole and oxazole cyclizations, occur
in posttranslationally modified microcins, a group of anti-
microbial peptides produced by, and active against, Gram-
negative bacteria (8). In these peptides the modification
reactions are dependent on the leader peptide. Cyclization
is also known for certain bacteriocins, e.g., circularin A (9)
and enterocin AS-48 (10), produced by Gram-positive
bacteria.
The present study concerns a special group of biologically,
or in vitro (11), synthesized dehydro residue- and (methyl)-
lanthionine-containing bacterial peptides. In these so-called
lantibiotics dehydroalanine and dehydrobutyrine result from
enzyme-mediated dehydration of serines and threonines.
Enzyme-catalyzed coupling of cysteines to dehydro residues
leads to thioether cyclizations. Instead of one head to tail
cyclization found in nonribosomal peptides, one to five ring-
like structures occur per lantibiotic (12-14). In naturally
occurring lantibiotics, these ring-like structures comprise a
thioether bond between neighboring amino acids or spaced
up to 19 amino acids. The position of these rings depends
on the positions of the dehydratable serines/threonines and
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cysteines in the peptide and on the cyclase-mediated regio-
and stereospecific ring closure. Thioether ring formation in
lantibiotics depends on the leader peptide (11). With respect
to the homology of the SapB modifying enzyme with serine/
threonine kinases (15), enzyme-mediated dehydration pos-
sibly occurs via phosphorylation of serines or threonines. A
mechanism for enzymatic thioether ring formation has been
proposed (16).
Lantibiotics are produced by and inhibit the growth of
Gram-positive bacteria (12, 14, 17-19). Nisin is the best
known and characterized lantibiotic (20, 21). It is widely
applied as a food additive (22). Previously, lantibiotics were
subdivided in elongated “type A” and globular “type B”
peptides (23). In type A lantibiotics a thioether ring is formed
between a serine or threonine with a more C-terminally
located cysteine. In type B lantibiotics also the inverse
orientation of the thioether ring occurs (14). Further sub-
groups have been distinguished: among others, a nisin
subgroup, a lacticin 481 subgroup, a mersacidin subgroup,
and a cinnamycin subgroup (14, 24). When a dehydrated
amino acid occurs in position +1, spontaneous deamination
takes place, resulting in an oxobutyryl residue. In epilancin
K7 (Figure 1D) this residue is reduced, forming a hydroxy-
propionyl residue (25, 26). Next to the (methyl)lanthionine
rings, some lantibiotics contain several other special amino
acids, e.g., D-alanines in lactocin S (Figure 1D). Other ring
structures are, for instance, (2S,8S)-lysinoalanine (occurring
in cinnamycin, duramycin, and duramycin B and C; Figure
1C), S-(Z)-aminovinyl-D-cysteine (in epidermin and galli-
dermin, Figure 1A; mersacidin, Figure 1C; and cypemycin,
Figure 1D).
Recently, we showed that the nisin-enzyme complex can
be dissected into active subcomplexes and that nonlantibiotic
peptides can also be modified and exported via the nisin
enzymes NisB1 and NisT. This enabled systematic studies
on the specificity of the lantibiotic enzymes. Despite the
existing data on lantibiotic structures until now no rules have
been defined that govern the posttranslational modifications.
Such rules might be extracted from the various known
lantibiotic structures. We hypothesized that the residues that
directly flank serines and threonines may affect the dehy-
dratase activity. Although the specificity of the modification
enzyme may be relaxed, and a strict motif may not exist,
there is a likelihood that certain residues are favored or
disfavored in close proximity of the residues to be modified.
The purpose of this study was to extract information from
existing lantibiotic structures to yield a predictive model that
can be used to design novel modified peptides. This
information was used to design a series of hexapeptides of
which the dehydration by NisB was experimentally inves-
tigated.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmids. Lactococcus lactis NZ9700
and NZ9000 (27) were used as hosts for expression of
peptides. Plasmids encoding leader peptide fusions, pTP-
ATVECK, pTP-ASVECK, pTP-ATVWCE, pTP-ASVWCE,
pTP-ITRICK, pTP-ITPGCK, pTP-DTRICK, pTP-ICPGTK,





from pNZnisA-E3 (28). pIL2angBTC was derived from
pIL253 (29) and codes for the nisin leader fused to NRSYICP
followed by the inverted repeat, present in the nisin gene
cluster, and the genes nisBTC. pIL2angBTC was constructed
as follows: pIL253 was digested with EcoRI and BamHI.
The chloramphenicol resistance marker (Cm) containing
fragment was amplified using the primers 5′-CCCCCCGAAT-
TCGGCCCGGGCCACACAGGCCGGCAATAGTTACC-
CTTATTATCAAGATAAG-3′, which introduces EcoRI
(underlined), SfiI (italics), and SmaI (bold) sites, and 5′-
GACTGCGGATCCGGCCTTGGTGGCCAGCTGTAATA-
TAAAAACCTTCTTCAACTAACG-3′, which introduces
SfiI (italics) and BamHI (underlined) sites. After digestion
of the amplified fragment with EcoRI and BamHI, it was
ligated into pIL253, resulting in pIL253Cm. From a pB-
MDL5 (28) derived vector, of which nisAB was replaced by
nisA-specR-nisB, a fragment containing Pnis-nisA-specR-
nisBTC was inserted in pIL253Cm, using PstI and XhoI sites,
resulting in pIL253CmI. The Cm and angiotensin coding part
of pLPang (28) was amplified with the primers 5′-CGC-
GGCCACACAGGCCAGTTCAACAAACGAAAATTGGA-
TAAAGTGGG-3′ and 5′-AATCAAGGCCTTGGTGGCCT-
TAAGGA CAAATATAAGAACG-3′ to introduce SfiI sites
on both ends. pIL253CmI and the amplified Cm-ang frag-
ment were both digested with SfiI and ligated. The resulting
plasmid was termed pILangBTC. Subsequently, the EmR
marker was removed by amplifying pILangBTC with the
primers 5′-ATACTAAGGCCGGGGGGGCCGGTTCGT-
GTTCGTGCTGACTTGC-3′ and 5′-GCAATATCAGTAAT-
TGCTTTATCAACTGC-3′. The obtained fragment was
digested with SnaBI and PmlI and ligated. The resulting low-
copy plasmid was termed pIL2angBTC.
The high-copy plasmid pIL3BTC, with a chloramphenicol
marker and without an erythromycin marker, was constructed
as follows: pILangBTC was amplified with the primers 5′-
ATACTAAGGCCGGGGGGGCCGGTTCGTGTTCGT-
GCTGACTTGC-3′ and 5′-GCAATATCAGTAATTGCTT-
TATCAACTGC-3′, after which the ends were made blunt
and ligated, resulting in pIL3angBTC. To eliminate angio-
tensin production, a stop codon was introduced in front of
the leader-angiotensin-coding part by amplification of
pIL3angBTC using the primers 5′-GTAGCGGCCGC-
AGATTTTAACTTGGATTTGGTATCTG-3′ and 5′-GTA-
GCGGCCGCCTATTTGAGTGCCTCCTTATAATTTAT-
TTTGTAG-3′, followed by restriction with NotI and ligation,
which led to pIL3BTC. No difference in peptide dehydration
was observed in cells containing pILang2BTC or pIL3BTC
except for DSRWARVALIDSQKAAVDKAITDIAEKL. This
peptide was dehydrated once when produced by cells
containing the high-copy plasmid pIL3BTC, but one and no
dehydration both occurred when it was produced by cells
containing the low-copy plasmid pILang2BTC, which is also
responsible for angiotensin production.
Molecular Cloning. Nisin leader constructs were made by
amplifying the pNZnisA-E3 plasmid (28) using a phospho-
1 Abbreviations: NisB, the nisin dehydratase; NisT, the nisin
transporter; NisC, the nisin cyclase; LanB, lantibiotic dehydratases;
LanM, lantibiotic enzymes that dehydrate and cyclize; TFA, trifluo-
roacetic acid; Maldi TOF, matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry.
8874 Biochemistry, Vol. 44, No. 24, 2005 Rink et al.
rylated downstream sense primer and an upstream antisense
primer with a (nonannealing) peptide-encoding tail. The
resulting linear leader peptide-encoding plasmid was self-
ligated and transformed to L. lactis NZ9000. DNA ampli-
fication was carried out using Expand polymerase (Invitro-
gen) or, in the case of large constructs, Phusion DNA
polymerase (Finnzymes). Ligation was carried out with T4
DNA ligase (Roche). Electrotransformation of L. lactis was
carried out as previously described (30) using a Bio-Rad gene
pulser (Bio-Rad, Richmond, CA). Nucleotide sequence
analysis was performed by BaseClear (Leiden, The Nether-
lands).
Culturing. L. lactis was grown in M17 broth (31)
supplemented with 0.5% glucose (GM17) or minimal
medium with or without chloramphenicol (5 íg/mL) and/or
erythromycin (5 íg/mL). The concentration of the antibiotics
was reduced to 4 íg/mL when both were present simulta-
neously. Minimal medium was prepared by adding 20 mL
of solution A [per 200 mL: 2.0 g of (NH4)2SO4, 6.0 g of
Na2HPO4, 3.0 g of KH2PO4, 1.0 g of NaCl] to 80 mL of
solution B [per 800 mL: 10.0 g of casamino acids, 2.0 g
of NaAc, 0.08 g of asparagine, 0.2 g of MgCl2, 0.01 g of
CaCl2, 0.6 mg of FeCl3(7H2O)], after which 2.5 mL of 20%
glucose and 100 íL of vitamin mix (per 100 mL: 0.01 g of
biotin, 0.1 g of folic acid, 0.1 g of riboflavin, 0.1 g of
nicotinic acid, 0.1 g of pantotheic acid, 0.2 g of pyridoxal)
were added. Prior to mass spectrometry, cells were cultured
and samples were prepared as follows. Overnight cultures
of L. lactis NZ9000 containing pIL2angBTC or pIL3BTC
and a second, nisin leader fusion-peptide-encoding plasmid,
grown in GM17 broth and 4 íg/mL antibiotics, were diluted
1/100. At an optical density at 600 nm of 0.4, cells were
centrifuged and the medium was replaced by minimal
medium supplemented with 1/1000 volume of filtered (0.45
ím) overnight L. lactis NZ9700 culture medium containing
nisin. Incubation was continued overnight. Prior to peptide
analysis on gel, cells were cultured in minimal medium
containing 0.12 M 3-(N-morpholino propanesulfonic acid
(MOPS), pH 7.
Gel Electrophoresis. Protein determinations were per-
formed using the DC protein assay of Bio-Rad. Peptides were
analyzed on tricine gels (32) and stained with Coomassie.
Samples were prepared as follows: 25 mL of culture
supernatant was filtered via 0.45 ím filters, freeze-dried,
resuspended in 2.5 mL of distilled water, and passed on a
PD10 column (Amersham), eluted with 3.5 mL of distilled
water and freeze-dried, and the equivalent of 3.3-10 mL of
culture supernatant was loaded on gel.
Peptide Modifications. Hydrogen additions to dehydro
residues in peptides were obtained as follows. Dried samples
were incubated overnight at room temperature with a 20 mg/
mL NaBH4 solution in 50 mM Tris-HCl, pH 7. After
subsequent acidification to pH 2 with 10% TFA solution and
purification by zipplate (Millipore), samples were dried,
followed by ethanethiol treatment (33) and zipplate purifica-
tion. The treatment was performed by using a mixture of 80
íL of ethanol, 65 íL of 5 M NaOH, and 60 íL of ethanethiol
in 400 íL of milliQ water to yield ethanethiol addition to
both rings and dehydro residues or by using a mixture of 80
íL of ethanol, 65 íL of 0.1 M NaOH, and 60 íL of
ethanethiol in 400 íL of milliQ water to effect ethanethiol
addition to only the dehydro residues. Trypsin treatment of
peptide, obtained by TCA precipitation of 20 mL of
supernatant, was performed in 10 íL of 0.1 M Tris-HCl,
pH 8.0, by incubation for 10 min with 0.02 mg/mL trypsin.
Mass Spectrometry. Peptides were isolated from culture
supernatants in a single step by applying the ziptip procedure
(C18 ziptip; Millipore). Ziptips were wetted and equilibrated
with 50% acetonitrile followed by demineralized water. Then
peptides from the medium were bound by subjecting 100
íL or more to ziptip treatment, washed with 0.1% TFA,
eluted with a solution of 0.1% TFA with 50% acetonitrile,
vacuum-dried, and stored at -20 °C until analysis. The dried
ziptip eluent was resuspended in 5 íL of 50% acetonitrile
containing 0.1% (v/v) TFA, and 1 íL was applied to the
target. Subsequently, 1 íL of matrix [10 mg/mL R-cyano-
4-hydroxycinnamic acid in 50% acetonitrile containing 0.1%
(v/v) TFA] was added to the target and allowed to dry.
Mass spectra were recorded with a Bruker Biflex III
MALDI-time-of-flight mass spectrometer. To maintain high
sensitivity, an external calibration was applied. The calibra-
tion was verified internally by the mass of the fusion peptide,
MSTKDFNLDLVSVSKKDSGASPRNRSYICP, which was
coexpressed in and secreted by the NZ9000 strain containing
the pIL2angBTC plasmid.
In Silico Analyses. Alignments were performed using the
Align X program of vector NTI. When determining the
abundance of modified or unmodified serines or threonines
or the abundance of specific residues N- or C-terminally from
serines or threonines, the following procedure was applied.
When two or more lantibiotics had all of the thioether rings
in an identical pattern, then overestimation of the occurrence
of specific residues was avoided by applying a weight factor.
In those cases identical unmodified residues, serines or
threonines, in homologous positions were counted as one
and identical flanking residues in homologous positions were
counted as one.
RESULTS
Flanking Amino Acids of Dehydrated Serines and Thre-
onines. We have compared lantibiotic structures with respect
to the occurrence of flanking residues of dehydrated serine
and threonine residues and of modified cysteine residues
(Figure 1). Alignment of unmodified lantibiotic propeptides
yielded three groups of which the structures with modifica-
tions are shown in Figure 1A-C. These groups differed in
their thioether ring patterns. One group shared the two most
N-terminal rings of epidermin (Figure 1A). A second group
shared the most N-terminal ring of variacin (Figure 1B),
while the third group shared all rings of ancovenin (Figure
1C). The remaining group (Figure 1D) is composed of
lantibiotics that, according to the alignment, have a different
structure from the lantibiotics classified to the first three
groups.
Serines and threonines in the leader peptides are never
dehydrated, but this may relate to the substrate recognition
mechanism that may involve binding of the leader peptide
at a binding site remote from the active site. Remarkably, in
the lantibiotics considered here, serines escaped dehydration
nearly twice as often as threonines (Table 1). For instance,
in nisin Ser29 remains unmodified and Ser33 sometimes
escapes modification (62). To extract general rules about
sequence motifs that favor dehydration of serine and threo-
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nine residues, we have analyzed the flanking amino acids
of these residues. In general, there is no strict sequence motif
that governs these modification reactions. Rather, there is a
preference for certain amino acids as flanking residues of
the modified serine and threonine residues. Hydrophobic,
especially nonaromatic, amino acids occurred more often as
flanking residues than hydrophilic, especially negatively
charged, amino acids (Figure 2). As a control, flanking
residues of serines and threonines in the enzymes LanB and
LanC were found to be more often hydrophilic than
hydrophobic. Taking into account that in some lantibiotics
unmodified serines and threonines are sometimes flanked by
a hydrophobic amino acid, no strict rule seems to exist.
Rather it seems that in lantibiotic propeptides hydrophobic,
nonaromatic, residues in the proximity of serines or thre-
onines are favorable for dehydration.
Ring Formation. Flanking residues of modified cysteines
were less hydrophobic than those of the converted serines
and threonines (Figure 2). Most rings are formed by coupling
of a dehydro residue to a more C-terminally located cysteine.
In only a few types of lantibiotics do rings with an inversed
orientation occur, i.e., formed by coupling of a dehydro
residue with a more N-terminally located cysteine. In the
latter case the flanking residues of modified cysteines,
serines, or threonines do not seem to be different from those
in peptides with commonly oriented rings. In lantibiotics
(methyl)lanthionine-forming cysteines occur much more
frequently than disulfide-forming cysteines. Interestingly, the
disulfide-forming cysteines of sublancin show little variation
in their flanking residues, being mostly glutamine and alanine
(Figure 1D). N-Terminally of (methyl)lanthionine-forming
cysteines, glutamate was relatively abundant in the lanti-
biotics depicted in Figure 1B. Ring formation is known to
be determined by intrinsic stereospecificity-determining
peptide structure (64-66) and regiospecificity-determining
cyclase activity (67).
Dehydration of Serines and Threonines in Model Peptides.
The flanking residues of the eight dehydratable serines and
threonines in prenisin vary, which indicates that the substrate
specificity of NisB is not strict. Indeed, we recently
demonstrated that also a nonlantibiotic peptide could be
dehydrated via NisB (28). To experimentally validate the
potential substrate preferences of LanB/LanM (Figure 2), we
designed a series of model peptides. According to our
analysis of lantibiotic structures, nonaromatic hydrophobic
amino acids, such as alanine and valine, are abundantly found
N- and C-terminally of dehydratable serines/threonines.
Therefore, NisB-mediated dehydration of serine/threonine is
expected to occur in the peptides A(S/T)VECK and A(S/
T)VWCE when these are fused to the nisin leader. The
cysteine in A(S/T)VECK is flanked by glutamate and lysine,
amino acids that frequently occur as respectively N- and
C-terminal flanking of cysteine in lantibiotics (Figure 2). On
the other hand, the cysteine in A(S/T)VWCE is flanked by
residues which rarely or not occur in these positions. In the
peptide ITRICK, the threonine is flanked by an isoleucine,
which frequently flanks dehydrated residues, and arginine,
which less frequently flanks dehydrated residues. The peptide
ITPGCK contains TPGCK, which is identical to unmodified
residues 31-35 of prenisin. This sequence is expected to be
fully modified because of its similarity with nisin’s ring B
and the presence of the isoleucine that N-terminally flanks
the threonine. As a control of the ITPGCK peptide, an
ICPGTK peptide was fused to the nisin leader peptide.
Hydrophilic and charged amino acids less frequently flank
the dehydratable serines/threonines. Aspartate and arginine
rarely occur respectively N- and C-terminally of the dehy-
drated residue. Therefore, no dehydration of the serine/
FIGURE 1: Alignment and structures of lantibiotics. Alignment of unmodified prosequences by the Align X program yielded three groups
depicted in panels A-C. Panel D depicts a remaining group that could not be aligned. Abbreviations: Dha, dehydroalanine; Dhb,
dehydrobutyrine; Abu, R-aminobutyric acid; A*, D-alanine; aI, alloisoleucine; Me2Ala, dimethylalanine.
Table 1: Serines and Threonines in Lantibiotics That Escape
Dehydrationa




a Analysis has been performed as described in the Experimental
Procedures section and is based on 37 lantibiotics.
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threonine is expected in the peptides D(S/T)RWCE, D(S/
T)RECK, and DTRICK. Another peptide was accidentally
obtained with an out of frame mutation, yielding the leader
peptide fused with DSRWARVALIDSQKAAVDKAITDI-
AEKL. Because of their flanking amino acids, the serine
residues in this peptide are not expected to be dehydrated,
whereas the threonine might be dehydrated. The isoleucine
at the N-side of the threonine may favor dehydration, whereas
the asparatate at the C-side makes dehydration less likely.
L. lactis NZ9000 containing pIL3BTC and a fusion
peptide-encoding plasmid produced all peptides in the culture
medium (Figure 3). Differences between the production
levels of the different peptides were measured; all levels were
much higher than 1 mg/L (data not shown). The secreted
peptides were analyzed by mass spectrometry (Table 2). They
all contained the leader peptide which lacked the N-terminal
methionine. In some cases additional N-terminal amino acids
were missing as, for instance, MS, MST, MSTK, and
MSTKD (Figure 4). Apparently, the leader peptide was
subject to N-terminal proteolytic degradation. The masses
of the observed designed peptides in which the threonine
was surrounded by at least one hydrophobic amino acid were
consistent with a single dehydration: leader-ATVECK,
leader-ATVWCE, leader-ITRICK, and leader-ITPGCK. For
leader-ASVECK and leader-ASVWCE next to the peaks
correponding to one time dehydration small peaks of
unmodified peptide were observed. For leader-ICPGTK a
heterogeneous product was obtained with either dehydrated
threonine or no dehydration at all. In contrast, no dehydration
was observed with leader-D(S/T)RWCE, leader-D(S/T)-
RECK, and leader-DTRICK. Since dehydration of the
threonine in ITRICK occurs but not in DTRICK, the lack
of dehydration can be ascribed to the N-terminal presence
of the aspartate. Cells containing pIlang2BTC and a plasmid
encoding leader-DSRWARVALIDSQKAAVDKAITDIAEKL
produced both an unmodified and a dehydrated form of this
longer peptide. Cells containing pIL3BTC and a plasmid
encoding this longer peptide produced a single dehydrated
peptide. Mass spectrometry of this peptide after trypsin
cleavage showed that all fragments comprising the threonine
position were dehydrated and could be modified by ethane-
thiol, leading to a mass increase of 62 Da. After trypsin
cleavage a mass peak of 1441 Da was observed, which
corresponds to residues 39-51 with one dehydration. This
peak shifted to 1503 Da after ethanethiol treatment, which
confirmed the dehydration. These data indicated that Thr45
was dehydrated and that neither Ser25 nor Ser35 were
dehydrated. This was confirmed by making three mutants:
Ser25Gly, Ser35Gly, and Thr45Gly. In the case of NZ9000
cells containing pIL3BTC and a plasmid, encoding either
the Ser25Gly or the Ser35Gly mutant, mass peaks of 5389
FIGURE 2: N- and C-terminal flankings of converted serines, threonines, and cysteines. Abbreviations: S*, dehydroalanine/D-alanine; T*,
dehydrobutyrine/R-aminobutyric acid; C*, cysteine-derived part of (methyl)lanthionine/vinylcysteine. The size of the letters corresponds to
the abundance in the indicated position.
FIGURE 3: Production of hexapeptides fused to the nisin leader. L.
lactis containing pIL3BTC and the fusion peptide-encoding plasmid
was cultured, and peptides were collected from the culture
supernatant as described in the Experimental Procedures section.
Peptides were composed of the nisin leader and the following
(hexa)peptides: ATVECK (1), ASVECK (2), ATVWCE (3),
ASVWCE (4), ITPGCK (5), ICPGTK (6), ITRICK (7), DTRICK
(8), DTRECK (9), DSRECK (10), DTRWCE (11), DSRWCE (12),
and DSRWARVALIDSQKAAVDKAITDIAEKL (13).
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Da would correspond to the mutant peptides in the absence
of dehydration. For both Gly mutants we observed mass
peaks of 18 Da lower, 5371 Da, which is consistent with
one time dehydration. On the other hand, replacement of the
Thr45 by Gly led to a mass peak of 5375 Da, consistent
with absence of dehydration. These data prove that Thr45 is
dehydrated but that neither Ser25 nor Ser35 are dehydrated.
Thr45 is preceded by the hydrophobic Ile, whereas Ser25
and Ser35 are flanked by hydrophilic amino acids and
preceded by an aspartate. Hence dehydration of Thr45 and
absence of dehydration of Ser25 and Ser35 are all in
agreement with Figure 2. Apparently, specific hexapeptides
and also peptides of 28 amino acids which are entirely
unrelated to lantibiotics can be modified and exported by
the nisin modification and export machinery, provided that
the N-terminal leader peptide is present. All peptide dehydra-
tions were confirmed as previously for the angiotensin variant
(28) by treatment with ethanethiol, which reacts with dehydro
residues and gives a mass increase of 62 Da.
Intramolecular coupling of cysteine to a dehydro residue
does not result in a change in mass. To discriminate between
peptides with dehydro residues and peptides with thioether
rings, peptides were subjected to chemical modifications,
followed by mass spectrometry. In one approach, the
treatment with borohydride caused hydrogen addition to
dehydro residues while it does not result in a mass change
in the case of a thioether ring. On the other hand, ethanethiol
is unable to react with dehydro residues that have undergone
hydrogen addition, whereas, at high NaOH concentration,
ethanethiol addition to peptide with the thioether ring still
takes place. In a second approach, peptides were treated with
ethanethiol at low NaOH concentration. Under these mild
reaction conditions, ethanethiol only reacts with occurring
dehydro residues. With this method, the presence of three
dehydro residues in nisin could be measured (data not
shown). Both methods indicated the presence of thioether
rings in the peptides ATVECK and ITPGCK but did not
yield conclusive results for other peptides (data not shown).
These results therefore indicate that a novel thioether ring,
comprising the combination of a valine and a glutamate, has
been generated in a model peptide.
DISCUSSION
Thioether rings are essential for lantibiotic activity (68,
69) and stability (1-3). Dehydro residues (70) and thiols
(69) have been engineered in nisin, while in Pep5 dehydro
residues and one new thioether ring have been introduced
(2). Recently, we have demonstrated that the substrate
specificity of the nisin dehydrating and transport enzymes
is not restricted to nisin alone but that the system can also
handle nonlantibiotic peptides. This indicates that lantibiotic
enzymes can be used for the synthesis of a wide range of
peptides with new bioactivities and of biostable analogues.
Here, we compared lantibiotic structures with the purpose
of deducing information on the substrate specificity of the
lantibiotic-modifying enzymes. This information can be used
for designing novel peptides. We hypothesized that the amino
acids that directly flank serines and threonines will affect
the dehydratase activity. Comparison of the structures
suggests that hydrophobic residues, mainly nonaromatic ones,
around the dehydratable amino acid may favor dehydration.
On the other hand, when polar and, in particular, negatively
charged amino acids are present, no dehydration is observed.
Therefore, the in silico data suggest that the vicinity of
hydrophobic amino acids next to serines or threonines would
be one of the circumstances that might promote dehydratase
activity.
It should be taken into account that the apparent in silico
data may not only reflect the substrate specificity of the
dehydratase enzyme but also include lantibiotic functioning.
For instance, the presence of negatively charged amino acids
in lantibiotics interferes with the interaction of the cationic
lantibiotic with the anionic target membrane (71, 72).
Furthermore, the absence of (full) dehydration might be due
to inefficient dehydration rather than an inability of the
enzymes to dehydrate this position. In the lantibiotics
depicted in Figure 1A,B,D, most thioether ring structures
Table 2: Dehydration and Export of Designed Fusion Peptidesa
theoretical av mass without
Met1 [M + H+] (Da)peptide C-terminally
fused to nisin leader
obsd
mass (Da) unmodified dehydrated
ATVECK 2965 2983 2965
ASVECK 2952 2970 2952
ATVWCE 3024 3041 3023
ASVWCE 3009 3028 3010
ITPGCK 2934 2951 2933
ICPGTK 2934/2952 2951 2933
ITRICK 3050 3067 3049
DTRICK 3069 3069 3051
DTRECK 3087 3085 3067
DSRECK 3070 3070 3052
DTRWCE 3144 3143 3125
DSRWCE 3129 3128 3110
DSRWARVALIDSQKA- 5401/5417 5418 5400 (1)
AVDKAITDIAEKL 5382 (2)
5364 (3)
a All serines and threonines are indicated in bold type.
FIGURE 4: N-Terminal truncation of peptide produced by L. lactis.
A supernatant of L. lactis NZ9000 cells containing pIL2angBTC
and pTP-ITPGCK was subjected to mass spectrometry analysis.
Masses correspond to the nisin leader peptide fused to dehydrated
ITPGCK without the initiating M (2934 Da), MS (2847 Da), MST
(2747 Da), MSTK (2618 Da), and MSTKD (2503 Da).
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involve two to four additional amino acids within the ring-
containing (methyl)lanthionines. This may imply that for
some lantibiotic cyclases larger ring structures might be less
easily formed. It cannot be excluded that coevolution of the
enzymes and their substrates has led to the exclusion of
dehydration reactions at positions that are too distant from
the cysteines for cyclization. Such positions may also not
contribute to lantibiotic functioning.
The theoretical analysis of the lantibiotic structures was
followed by an experimental approach in which the NisB-
mediated dehydration of designed peptides was tested. These
peptides were designed such that they represented extreme
cases with respect to the likelihood of modification as
suggested by the in silico analyses. Studies on the substrate
specificity of lantibiotic enzymes have been hampered for a
long time because of the lack of production or detection of
produced peptides. In this study we demonstrate that a series
of rationally designed peptides is produced, exported, and
modified. Most interestingly, all peptide modifications were
found to conform to our theoretical prediction, showing that
the dehydration reaction at least follows some guidelines that
can be applied in successful production of modified peptides.
Several, but not strictly all, previously reported lantibiotic
mutants (21, 73, 74) are in agreement with our predictions.
Interestingly, V32E and V32K nisin Z (71) share the presence
of an unmodified serine at position 33. Since hydrophilic
residues are not preferred around dehydratable serines and
threonines, these mutants are indeed predicted not to be
dehydrated. In addition, in lantibiotics, glutamate residues
are rarely (subtilin and ericin-S) observed N-terminally of
dehydratable serine residues. Nisin has a lysine at position
34 following the serine at position 33. With the V32E and
V32K mutants, serine 33 is surrounded by charged residues,
which is unfavorable for dehydration.
Previously, the export of a nonlantibiotic peptide NRSY-
ICP was observed concomitantly with partial dehydration
(28). This can be most likely attributed to the presence of
Arg N-terminally of Ser. In the designed peptides described
here, hydrophobic flankings of dehydratable residues such
as alanine and valine allowed full dehydration. Also, the
positive control, peptide ITPGCK, which is related to ring
B of nisin, was fully dehydrated. In sharp contrast, no
dehydration of serines/threonines was observed in five
designed peptides when these serines/threonines were N-
terminally preceded by an aspartate and C-terminally flanked
by an arginine. These data again correspond with the in silico
analysis and strongly indicate that known lantibiotic struc-
tures can be used to deduce guidelines for the designing of
posttranslationally modified peptides. Therefore, peptide
design and experimental analyses constitute a valuable
approach to study remaining questions about the dehydration
and thioether bridge formation by lantibiotic enzymes.
Summarizing, this study for the first time demonstrates that
in nonlantibiotic peptides the extent of dehydration can be
controlled by the amino acid context of the flanking region
of the dehydratable serine and threonine residues. The here
used system allows the production of considerable amounts
of modified peptides. We are currently investigating whether
the flanking residues of cysteines influence NisC-mediated
ring formation. Such studies will further contribute to the
rational design and enzymatic synthesis of a wide range of
new biostable thioether ring-containing peptides.
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